In an important milestone towards market introduction, Median Technologies announces that its CADe/CADx Software as Medical Device (SaMD), eyonis™ LCS, has demonstrated excellent performance in an ...
SOPHIA ANTIPOLIS, France - Median Technologies has announced a significant advancement in its lung cancer screening technology, eyonis™ LCS, following an independent verification study. The software, ...
In an important milestone towards market introduction, Median Technologies announces that its CADe/CADx Software as Medical Device (SaMD), eyonis LCS, has demonstrated excellent performance in an ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈